CDKN2A and renal cell carcinoma: Methylated p14ARF was significantly associated with gender, in which it was lower in males than in females, suggesting that female RCC patients can be more susceptible to p14ARF promoter methylation, whereas methylated p16INK4A had a similar frequency in males and females.